One of these immunomodulatory molecules is the enzyme indoleamine 2,3-dioxygenase (IDO), which creates an immunosuppressive environment by depleting tryptophan and releasing metabolites that inhibit T cell proliferation and function while promoting tumor survival and motility [175]. The gene discussed is IDO2; the disease is neoplasm.